Video

Renee L. Williams, MD: The Importance of Colonoscopies

Author(s):

"The best test is the 1 that gets done," Williams said.

Colonoscopies still remain the best option for screening patients for colorectal cancer.

In an interview with HCPLive® during the 2022 American College of Gastroenterology (ACG) Annual Meeting in Charlotte, Renee L. Williams, MD, Associate Professor of Medicine at NYU Langone discussed how important it is for individuals to get a colonoscopy once they turn 45 years.

Williams talked in favor of the recent decision to reduce the recommended age for colorectal cancer screenings from 50 years to 45 years. She said the move was especially important because there has been an increase in incidence of colorectal cancers in recent years, particularly among younger individuals.

In recent weeks there has been a debate over whether colonoscopies are the best screening option for colorectal cancers. However, adherence to tests is likely the most important factor over which screening tool is used.

“I think the best test is the 1 that gets done,” Williams said.

However, she also said colonoscopies still remain the best option.

“The thing about colonoscopies is that it is a 1 stop shop,” Williams said. “Essentially we go in and we see something and take it out.”

She said the advantage of the colonoscopy is that if another test, such as a stool-based test, is positive, the patient will still need a colonoscopy.

Related Videos
Ladan Zand, MD: Evaluating Obinutuzumab in Primary FSGS and Further Research
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Kishore Iyer, MD , MBBS | Credit: Kishore Iyer on LinkedIn
Evan Dellon, MD, MPH | Credit: UNC Chapel Hill
Marlyn Mayo, MD | Credit: ACG
Kishore Iyer, MD, MBBS | Credit: Kishore Iyer on LinkedIn
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
Bruce Sands, MD | Credit: Alimentiv
Andrea Murina, MD: Drug Pipeline for Hidradenitis Suppurativa
Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University
© 2024 MJH Life Sciences

All rights reserved.